医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.

广告
第一作者: Stefano,Kim
第一单位: Clinical Investigation Centre 1431, University Hospital of Besançon, Besançon, France; National Institute of Health and Medical Research (INSERM), Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Oncology Multidisciplinary Group (GERCOR), Paris, France; Fédération Francophone de Cancérologie Digestive, Paris, France; Department of Oncology, Sanatorio Allende, Cordoba, Argentina. Electronic address: stefano.kim@inserm.fr.
作者单位: Clinical Investigation Centre 1431, University Hospital of Besançon, Besançon, France; National Institute of Health and Medical Research (INSERM), Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Oncology Multidisciplinary Group (GERCOR), Paris, France; Fédération Francophone de Cancérologie Digestive, Paris, France; Department of Oncology, Sanatorio Allende, Cordoba, Argentina. Electronic address: stefano.kim@inserm.fr. [1] Department of Oncology, Centre Georges-François Leclerc, Dijon, France. [2] Department of Oncology, Centre Léon Bérard, Lyon, France. [3] Department of Oncology, Centre Antoine-Lacassagne, Nice, France. [4] Department of Oncology, University Hospital of Bordeaux, Bordeaux, France. [5] Department of Radiology, Clinique Saint Vincent, Besançon, France. [6] Department of Oncology, Montpellier Cancer Institute, Montpellier, France. [7] Department of Oncology, Sorbonne University and Hospital Saint Antoine, Paris, France. [8] Department of Oncology, Centre François Baclesse, Caen, France. [9] Department of Oncology, Jean Mermoz Private Hospital, Lyon, France. [10] Department of Oncology, Paris Saint-Joseph Hospital Group, Paris, France. [11] Department of Oncology, Curie Institute, Paris, France. [12] Department of Gastroenterology and Hepatology, University Hospital of Poitiers, Poitiers, France. [13] Department of Digestive Oncology, University Hospital of Reims, Reims, France. [14] Department of Oncology, University Hospital Timone, Marseille, France. [15] Department of Oncology, Hôpital Franco-Britannique-Fondation Cognacq-Jay, Cancérologie Paris Ouest, Levallois-Perret, France. [16] Department of Oncology, Centre Oscar Lambret, Lille, France. [17] Gastrointestinal and Liver Oncology Unit, St Catherine Institute of Cancer Avignon-Provence, Avignon, France. [18] Department of Digestive Oncology, Diaconesses Croix Saint Simon Hospital Group, Paris, France. [19] Department of Medical Oncology, Paul Strauss Centre, Strasbourg, France. [20] Gastrointestinal Oncology Unit, Institute of Digestive Diseases, Nantes University Hospital, Nantes, France. [21] Department of Pathology, University Hospital of Besançon, Besançon, France. [22] Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium. [23] Oncology Multidisciplinary Group (GERCOR), Paris, France; Department of Oncology, Sorbonne University and Hospital Saint Antoine, Paris, France. [24] Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France; National Institute of Health and Medical Research (INSERM), Unit 1098, University of Bourgogne Franche-Comté, Besançon, France. [25] Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France; National Institute of Health and Medical Research (INSERM), Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Oncology Multidisciplinary Group (GERCOR), Paris, France. [26] Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris-Cité University, SIRIC CARPEM Comprehensive Cancer Centre, Paris, France. [27] Clinical Investigation Centre 1431, University Hospital of Besançon, Besançon, France; Department of Oncology, University Hospital of Besançon, Besançon, France; National Institute of Health and Medical Research (INSERM), Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Oncology Multidisciplinary Group (GERCOR), Paris, France; Fédération Francophone de Cancérologie Digestive, Paris, France. [28]
DOI 10.1016/S1470-2045(24)00081-0
PMID 38547895
发布时间 2026-03-24
提交
  • 浏览0
The Lancet. Oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷